Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 1 - 10 of 57

Selected Filters:
19 May 2025

Vision to Action: Unveiling the national black HIV prevention research agenda

This webinar will introduce a bold, Black-led blueprint designed to guide HIV prevention research that centers the needs, voices, and leadership of Black communities across the United States. Developed through conversations with over 1,000 Black researchers, community members, and health advocates, this agenda represents a national call to align research, funding, and policy with the…

Community/Advocacy, Research

Event
17 February 2025

Advancing PrEP Access and Uptake Among Gay Men of Color

This advocacy brief, compiled by NMAC, presents the results of a community-led study to uncover barriers and facilitators to PrEP uptake amongst gay and bisexual men of color. The brief also identifies actionable themes and proposes a three-year advocacy agenda to address disparities and improve health outcomes.

Community/Advocacy, Research

External Link
3 February 2025

Interest in Injectable and Oral PrEP for HIV Prevention Among Women and Men Who Inject Drugs

This article from Journal of Addiction Medicine examines interests and concerns around use of oral and injectable PrEP amongst people who inject drugs in the United States.

Research

External Link
4 December 2024

I Am More Than HIV Prevention: Results from the HPTN 091 study with transgender women

HPTN 091, the I Am study, evaluated the impact of a multicomponent HIV prevention strategy to increase the uptake and adherence of pre-exposure prophylaxis (PrEP) among transgender women. The strategy included HIV prevention services, gender-affirming hormone therapy, and peer health navigation. This webinar will feature Dr. Tonia Poteat, Ph.D., Duke University School of Nursing, Division…

Research

Event
29 November 2024

Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons

This article from the New England Journal of Medicine describes the results of PURPOSE 2, the Phase III clinical trial for injectable lenacapavir for PrEP, carried out amongst gay and bisexual men who have sex with men, trans men, trans women, and gender non binary individuals in Argentina, Brazil, Mexico, Peru, South Africa, Thailand, and…

Research

External Link
15 August 2024

Let’s Talk LEN: What global advances in HIV prevention mean for Black communities in the US

Groundbreaking results from the PURPOSE 1 trial conducted among cisgender Ugandan and South African women have changed the injectable PrEP global landscape. This webinar will explore the implications of these findings for US Black populations. Moderators: John Meade Jr., Senior Program Manager, Policy at AVAC & Founding Member of PrEP in Black America (PIBA) Leisha…

Community/Advocacy, Research

Event
12 August 2024

PrEP Your Booty: The Launch of HPTN 106 “Rev Up”

Recording / Slides / Resources HPTN 106 (REV UP) is an innovative clinical trial from the HIV Prevention Trials Network that will investigate the safety and acceptability of a tenofovir-based rectal douche for HIV prevention among cisgender men and transgender women who have sex with men. Hear directly from researchers leading the study during this…

Research

Event
7 August 2024

Opportunities to Expand Equitable Access to HIV Prevention Services through Community Pharmacies

RxEACH is a national coalition effort working to expand and sustain access to HIV prevention and linkage to care services in community pharmacies. Community pharmacies are poised to unlock access to HIV prevention services, particularly in areas where it is most needed, and can play a crucial role in achieving equitable PrEP access. With over…

Service Delivery

Event
10 June 2024

HPTN 083-02: Factors influencing adherence to injectable PrEP and retention in an injectable PrEP study

This article from Journal of the International AIDS Society to explores the experiences of participants in the HPTN-083 trial, which evaluated safety and efficacy of cabotegravir for PrEP, including barriers to adherence and other factors that may have impacted study implementation or outcomes.

Research

External Link
25 April 2024

Equity of PrEP uptake by race, ethnicity, sex and region in the United States in the first decade of PrEP: A population-based analysis

This article from The Lancet Regional Health- Americas describes trends in PrEP uptake during the first ten years of PrEP provision in the United States by race, ethnicity, sex, and region.

Research

External Link